ORMP Oramed Pharmaceuticals Inc. - Common Stock
$4,83
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla Ağu 10, 2026
52 Haftlık Aralık
$2–$5
89% of range
Analist Derecelendirmesi
HOLD
6 analysts
Fiyat Hedefi
$6
+29% upside
P/E (TTM)
0.0
ROE
37.0%
Net Kâr Marjı
3202.5%
Oramed Pharmaceuticals Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.
Devamını oku
Oramed Pharmaceuticals Inc. (Hebrew: אורמד), is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.
History
Oramed Pharmaceuticals was founded in 2006 by Miriam Kidron, a scientist at the Hadassah University Hospital in Jerusalem, and her son Nadav Kidron.
Product pipeline
Oramed considers its flagship product to be an oral insulin capsule developed to treat sufferers of type 2 diabetes. The Company is currently conducting Phase 3 trials, under the FDA, for oral insulin in Type 2 diabetes.
In addition to the oral insulin capsule, Oramed is developing an exenatide-based capsule designed to balance blood sugar levels and control appetite, and is conducting clinical trials for the treatment of NASH with oral insulin.
In 2021, Oramed created a subsidiary, Oravax Medical, to bring an oral Covid-19 vaccine to market.
In January 2023, a Phase 3 trial of Oramed's orally administered insulin for Type 2 diabetes patients failed, thus causing the share price to plunge. The company has mentioned that the pill worked for a subset of the population and will pursue a Phase 3 trial for that subset.
In May 2023, Ben Shapiro invested $4.7 million and was named to the board of directors.
On May 15, 2023, it was reported that Oramed's insulin pill was approved in China and will work with a Chinese firm to apply for marketing authorizations.
Subsidiaries
OraTech Pharmaceuticals is a joint venture formed by Oramed Pharmaceuticals and Hefei Tianhui Biotech, to commercialize its insulin capsule and is expected to list on the NASDAQ sometime in 2025.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
ORMP Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$4.83
Piyasa Değeri
$197.7K
P/E (TTM)
0.0
EPS (TTM)
$1.50
Gelir (TTM)
$2M
Temettü Verimi
—
ROE
37.0%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$2 – $5
ORMP Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$2M
2017-08-31
→
2025-12-31
Hisse Başına Kâr
$1.50
2022-12-31
→
2025-12-31
Serbest Nakit Akışı
$-9M
2019-08-31
→
2025-12-31
Marjlar
3202.5%
2025-12-31
→
2025-12-31
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
ORMP
Akran Ortalaması
P/E (TTM)
0.0
23.4
P/S (TTM) (F/S (TTM))
0.1
11.2
P/B (F/D)
0.0
2.5
Price / FCF (Fiyat / Serbest Nakit Akışı)
-0.0
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
ORMP
Akran Ortalaması
Gross Margin (Brüt Kar Marjı)
0.65%
82.8%
Operating Margin (Faaliyet Kâr Marjı)
-754.4%
—
Net Profit Margin (Net Kâr Marjı)
3202.5%
-199.7%
ROA
33.2%
-34.8%
ROE
37.0%
-33.2%
ROIC
-6.4%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
ORMP
Akran Ortalaması
Current Ratio (Cari Oran)
7.0
1.5
Quick Ratio (Cari Oran)
2.7
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
ORMP
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
-50.4%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
-9.6%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
ORMP
Akran Ortalaması
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
Temettü Verimi
—
Temettü Ödeme Oranı
—
5 Yıllık Temettü CAGR
—
| Ex-tarihi | Miktar |
|---|---|
| 16 Ocak 2026 | $0,2500 |
ORMP Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
SAT
6 analist
- Güçlü Al 0 0,0%
- Al 0 0,0%
- Tut 3 50,0%
- Sat 1 16,7%
- Güçlü Sat 2 33,3%
12 Aylık Fiyat Hedefi
1 analist · 2026-08-17
Düşük
$6.25
Yüksek
$6.25
Medyan hedef
$6.25
+29,4%
Ortalama hedef
$6.25
+29,4%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.32%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Aralık 2025 | $0.24 | $0.00 | 0.24% |
| 30 Eylül 2025 | $1.12 | $-0.04 | 1.2% |
| 30 Haziran 2025 | $0.31 | $-0.04 | 0.35% |
| 31 Mart 2025 | $-0.19 | $-0.01 | -0.18% |
| 31 Aralık 2024 | $0.00 | $-0.03 | 0.03% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ORMP | $112M | 1.9 | -50.4% | 3202.5% | 37.0% | 0.65% |
| TTRX | $116M | -32.8 | — | — | -141.7% | — |
| ANTX | $31M | -1.0 | — | — | -57.7% | — |
| SIGA | $438M | 19.1 | -31.8% | 24.6% | 11.4% | — |
| DERM | — | -16.4 | 10.2% | -18.5% | -44.7% | — |
| LENZ | $502M | -5.6 | — | -430.2% | -33.5% | — |
| NRXP | — | — | — | — | — | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | · | $1M | $3M | · | $3M | $3M | $2M | $2M | |
| Cost of Revenue | $2M | · | · | · | · | · | $90.0K | $-86.0K | $187.0K | |
| Gross Profit | $13.0K | · | · | · | · | · | · | · | · | |
| R&D Expense | $6M | $6M | $9M | $28M | · | $10M | $14M | $12M | $10M | |
| SG&A Expense | $9M | $6M | $8M | $14M | · | $4M | $4M | $4M | $3M | |
| Operating Income | $-15M | $-13M | $-16M | $-41M | · | $-12M | $-15M | $-14M | $-11M | |
| Interest Expense | · | · | $2M | · | · | · | · | · | · | |
| Interest Income | · | · | $10.0K | · | · | · | · | · | · | |
| Other Non-op | $-606.0K | $-27.0K | $13.3K | $3M | · | · | · | · | · | |
| Pretax Income | $75M | $-16M | $5M | $-38M | · | $-12M | $-14M | $-13M | $-10M | |
| Income Tax | $11M | $3M | · | $100.0K | · | · | $300.0K | · | $400.0K | |
| Net Income | $64M | $-19M | $5M | $-37M | · | $-12M | $-14M | $-13M | $-10M | |
| EPS (Basic) | $1.53 | $-0.48 | $0.14 | $-0.94 | · | · | · | · | · | |
| EPS (Diluted) | $1.50 | $-0.48 | $0.14 | $-0.94 | · | · | · | · | · | |
| Shares (Basic) | 41,402,997 | 40,850,446 | 40,315,068 | 38,997,649 | · | · | · | · | · | |
| Shares (Diluted) | 42,418,644 | 40,850,446 | 40,566,901 | 38,997,649 | · | · | · | · | · | |
| EBITDA | $-15M | · | $-16M | $-41M | · | $-12M | $-15M | · | · |
Bilanço 23
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $54M | $9M | $40M | · | $19M | $3M | $5M | $4M | |
| Short-term Investments | $5M | $3M | · | · | $8M | $3M | · | $5M | · | |
| Prepaid Expense | $3M | $1M | $537.0K | $1M | · | $611.0K | $1M | $574.0K | · | |
| Current Assets | $133M | $143M | $163M | $157M | $148M | $41M | $33M | $31M | · | |
| PP&E (Net) | $586.0K | $698.0K | $873.0K | $815.0K | $388.0K | $99.0K | $24.0K | $17.0K | · | |
| Other Non-current Assets | $44.0K | $32.0K | $27.0K | · | · | · | · | · | · | |
| Total Assets | $231M | $155M | $221M | $162M | $178M | $45M | $35M | $47M | · | |
| Accounts Payable | $443.0K | $789.0K | $551.0K | $4M | $5M | $2M | $3M | $2M | · | |
| Accrued Liabilities | $1M | $402.0K | $605.0K | · | · | · | · | · | · | |
| Short-term Debt | $652.0K | $329.0K | $51M | · | · | · | $3M | $2M | · | |
| Current Liabilities | $19M | $6M | $53M | $6M | $7M | $5M | $5M | $5M | · | |
| Capital Leases | $540.0K | $156.0K | $342.0K | $647.0K | $370.0K | $31.0K | · | · | · | |
| Deferred Tax | $8M | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | $60.0K | $63.0K | · | · | $211.0K | $271.0K | $313.0K | · | |
| Long-term Debt | · | · | · | $25.0K | $12M | · | $10M | $11M | · | |
| Total Debt | · | · | $51M | · | · | · | $3M | · | · | |
| Common Stock | $472.0K | $480.0K | $485.0K | $476.0K | $459.0K | $284.0K | $208.0K | $207.0K | · | |
| Paid-in Capital | · | · | · | $314M | $293M | $125M | · | · | · | |
| Retained Earnings | $-123M | $-177M | $-158M | $-163M | $-127M | $-93M | $-81M | $-69M | · | |
| AOCI | · | · | · | · | · | · | · | $702.0K | · | |
| Stockholders' Equity | $200M | $145M | $164M | $152M | $166M | $33M | $19M | $31M | $19M | |
| Liabilities + Equity | $231M | $155M | $221M | $162M | $178M | $45M | $35M | $47M | · | |
| Shares Outstanding | 39,275,006 | 39,920 | 40,339,000 | 39,564,000 | 38,158 | 23,675,530 | 17,383,359 | 17,369,875 | · |
Nakit Akışı 12
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $4M | $4M | $12M | · | $465.0K | $808.0K | $2M | $2M | |
| Deferred Tax | $8M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-8M | $-10M | $-28M | · | $-12M | $-13M | $-15M | $-6M | |
| CapEx | $9.0K | $18.0K | $254.0K | $496.0K | · | $82.0K | $15.0K | $5.0K | $7.0K | |
| Investing Cash Flow | $5M | $106M | $-73M | $30M | · | $5M | $11M | $-7M | $4M | |
| Stock Issued | · | · | $2M | $12M | · | · | · | · | · | |
| Stock Repurchased | $5M | $2M | · | · | · | · | · | · | · | |
| Net Stock Activity | $-5M | · | $2M | $11M | · | · | · | · | · | |
| Financing Cash Flow | $-5M | $-52M | $52M | $11M | · | $24M | · | $23M | $2M | |
| Net Change in Cash | $-8M | $45M | $-31M | $13M | · | $16M | $-2M | $1M | $62.0K | |
| Taxes Paid | · | $2M | · | $2M | · | · | $300.0K | · | $400.0K | |
| Free Cash Flow | $-9M | · | $-11M | $-28M | · | $-13M | $-13M | · | · |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 0.65% | · | · | · | · | · | · | · | · | |
| Operating Margin | -754.4% | · | -1176.8% | -1502.0% | · | -433.8% | -541.3% | · | · | |
| Net Margin | 3202.5% | · | 412.3% | -1397.1% | · | -424.8% | -531.1% | · | · | |
| Pretax Margin | 3766.2% | · | 379.7% | · | · | -424.8% | -520.0% | · | · | |
| EBITDA Margin | -754.4% | · | -1176.8% | -1502.0% | · | -433.8% | -541.3% | · | · | |
| ROA | 33.2% | · | 2.9% | -22.2% | · | -29.0% | -35.0% | · | · | |
| ROE | 37.0% | · | 3.5% | -23.7% | · | -47.0% | -70.1% | · | · | |
| ROIC | -6.4% | · | · | · | · | · | -67.6% | · | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | · | 3.1 | 27.3 | · | 8.9 | 6.3 | · | · | |
| Quick Ratio | 2.7 | · | 1.3 | 0.7 | · | 5.0 | 1.3 | · | · | |
| Debt / Equity | · | · | 0.3 | · | · | · | 0.1 | · | · | |
| Interest Coverage | · | · | -7.7 | · | · | · | · | · | · |
Verimlilik 1
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | · | 0.1 | 0.1 | · | · |
Büyüme Oranları 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -50.4% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -9.6% | · | · | · | · | · | · | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $3M | $1M | $3M | · | $3M | $3M | $2M | $2M | |
| Net Income TTM | $64M | $-19M | $5M | $-37M | · | $-12M | $-14M | $-13M | $-10M | |
| Market Cap | $112M | · | $93M | $476M | · | $83M | $58M | · | · | |
| Enterprise Value | · | · | $77M | · | · | · | $53M | · | · | |
| P/E | 1.9 | -5.0 | 16.5 | -12.8 | · | · | · | · | · | |
| P/S | 56.0 | · | 69.5 | 176.1 | · | 30.5 | 21.4 | · | · | |
| P/B | 0.6 | · | 0.6 | 3.1 | · | 2.5 | 3.0 | · | · | |
| P / Tangible Book | 0.6 | 0.7 | 0.6 | 3.1 | · | 2.5 | · | · | · | |
| P / Cash Flow | -12.2 | · | -9.1 | -17.0 | · | -6.6 | -4.5 | · | · | |
| P / FCF | -12.2 | · | -8.8 | -16.8 | · | -6.6 | -4.5 | · | · | |
| EV / EBITDA | · | · | -4.9 | · | · | · | -3.6 | · | · | |
| EV / FCF | · | · | -7.3 | · | · | · | -4.1 | · | · | |
| EV / Revenue | · | · | 57.8 | · | · | · | 19.8 | · | · | |
| Earnings Yield | 52.6% | -19.8% | 6.1% | -7.8% | · | · | · | · | · |
Gelir Tablosu 17
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | · | · | $2M | · | · | · | · | $0 | · | $674.0K | $666.0K | $681.0K | $682.0K | |
| Cost of Revenue | · | · | $0 | · | · | $2M | · | · | · | · | · | · | · | · | · | · | |
| Gross Profit | · | · | $0 | · | · | $13.0K | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | · | $2M | $2M | $1M | $1M | $2M | $1M | $2M | $1M | $1M | $2M | $957.0K | $2M | $4M | $7M | $5M | |
| SG&A Expense | $3M | $2M | $4M | $1M | $1M | $2M | $2M | $847.0K | $2M | $2M | $2M | $3M | $2M | $1M | $3M | $3M | |
| Operating Expenses | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $11.0K | |
| Operating Income | $-3M | $-4M | $-6M | $-2M | $-2M | $-4M | $-4M | $-3M | $-3M | $-3M | $-4M | $-3M | $-4M | $-5M | $-10M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $592.0K | · | $826.0K | · | · | · | · | |
| Other Non-op | $-4.0K | $-100.0K | $-74M | $61M | · | $-143.0K | $-2M | $-15M | $14M | $4M | $-4M | $435.0K | $2M | $2M | $1M | $1M | |
| Pretax Income | $102M | $49M | $10M | $59M | $13M | $-7M | $-10M | $-19M | $11M | $2M | $13M | $-3M | $-1M | · | $-9M | $-7M | |
| Income Tax | $23M | $11M | $-212.0K | $11M | $-126.0K | $584.0K | $416.0K | $1M | $2M | · | · | · | · | · | $0 | $100.0K | |
| Net Income | $78M | $38M | $10M | $48M | $13M | $-8M | $-10M | $-20M | $9M | $2M | $13M | $-3M | $-1M | $-3M | $-8M | $-7M | |
| EPS (Basic) | $1.90 | $0.94 | $0.24 | $1.16 | $0.32 | $-0.19 | $-0.26 | $-0.48 | $0.22 | $0.04 | $0.33 | $-0.08 | $-0.03 | $-0.08 | $-1.66 | $0.18 | |
| EPS (Diluted) | $1.84 | $0.91 | $0.25 | $1.13 | $0.31 | $-0.19 | $-0.26 | $-0.48 | $0.22 | $0.04 | $0.33 | $-0.08 | $-0.03 | $-0.08 | $-1.66 | $0.18 | |
| Shares (Basic) | 41,040,479 | 40,773,866 | -83,325,572 | 41,756,301 | 41,743,486 | 41,228,782 | -81,842,111 | 40,896,845 | 40,959,759 | 40,835,953 | -80,397,680 | 40,445,896 | 40,225,594 | 40,041,258 | -77,577,522 | 39,100,231 | |
| Shares (Diluted) | 42,501,252 | 41,970,186 | -84,194,067 | 42,774,504 | 42,609,425 | 41,228,782 | -83,201,413 | 40,896,845 | 41,591,007 | 41,564,007 | -80,145,847 | 40,445,896 | 40,225,594 | 40,041,258 | -77,577,522 | 39,100,231 | |
| EBITDA | $-3M | $-4M | · | $-2M | $-2M | $-4M | · | $-3M | $-3M | $-3M | · | $-3M | $-4M | $-5M | · | $-8M |
Bilanço 22
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15M | $13M | $46M | $52M | $16M | · | $54M | · | $10M | $19M | · | · | · | · | $40M | · | |
| Short-term Investments | $846.0K | $5M | $5M | $5M | $2M | $4M | $3M | $57M | $66M | $78M | · | $49.4K | $943.0K | $2M | · | $5M | |
| Prepaid Expense | $2M | $2M | $3M | $1M | $1M | $832.0K | $1M | $474.0K | $533.0K | $501.0K | $537.0K | $666.0K | $769.0K | · | $1M | · | |
| Current Assets | $53M | $68M | $133M | $136M | $99M | $131M | $143M | $143M | $153M | $177M | $163M | $176M | $151M | $155M | $157M | $160M | |
| PP&E (Net) | $532.0K | $561.0K | $586.0K | $614.0K | $645.0K | $671.0K | $698.0K | $718.0K | $765.0K | $819.0K | $873.0K | $923.0K | $945.0K | $977.0K | $815.0K | $535.0K | |
| Other Non-current Assets | $49.0K | $46.0K | $44.0K | $40.0K | $38.0K | $32.0K | $32.0K | · | · | · | $27.0K | · | · | · | · | · | |
| Total Assets | $370M | $269M | $231M | $220M | $162M | $148M | $155M | $165M | $184M | $204M | $221M | $231M | $156M | $160M | $162M | $164M | |
| Accounts Payable | $374.0K | $481.0K | $443.0K | $560.0K | $715.0K | $509.0K | $789.0K | $5M | $3M | $1M | $551.0K | $3M | $828.0K | $4M | $4M | $4M | |
| Accrued Liabilities | $1M | $1M | $1M | $585.0K | $841.0K | $800.0K | $402.0K | · | · | · | $605.0K | · | · | · | · | · | |
| Short-term Debt | · | · | · | $1.0K | $34.0K | $36.0K | · | · | · | $32M | $51M | $75M | $3.0K | $1.0K | · | · | |
| Current Liabilities | $11M | $11M | $19M | $6M | $4M | $5M | $6M | $5M | $4M | $34M | $53M | $78M | $1M | $5M | $6M | $7M | |
| Capital Leases | $484.0K | $493.0K | $540.0K | $589.0K | $648.0K | $120.0K | $156.0K | $186.0K | $236.0K | $272.0K | $342.0K | $389.0K | $488.0K | $564.0K | $647.0K | $672.0K | |
| Deferred Tax | $40M | $18M | $8M | $8M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $60.0K | $60.0K | $60.0K | · | $63.0K | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $75M | · | · | · | $5M | |
| Total Debt | · | · | · | $1.0K | $34.0K | $36.0K | · | · | · | $32M | · | $75M | $3.0K | $1.0K | · | · | |
| Common Stock | $495.0K | $491.0K | $472.0K | $490.0K | $491.0K | $491.0K | $480.0K | $484.0K | $488.0K | $487.0K | $485.0K | $484.0K | $484.0K | $481.0K | $476.0K | $470.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | · | $319M | $317M | · | $308M | |
| Retained Earnings | $-7M | $-85M | $-123M | $-123M | $-171M | $-184M | $-177M | $-166M | $-147M | $-156M | $-158M | $-171M | $-168M | $-166M | $-163M | $-155M | |
| Stockholders' Equity | $317M | $238M | $200M | $203M | $155M | $141M | $146M | $156M | $177M | $167M | $164M | $149M | $152M | $151M | $152M | $154M | |
| Liabilities + Equity | $370M | $269M | $231M | $220M | $162M | $148M | $155M | $165M | $184M | $204M | $221M | $231M | $156M | $160M | $162M | $164M | |
| Shares Outstanding | 41,314,211 | 40,926,081 | 39,275,006 | 40,838,226 | 40,845,087 | 40,850,455 | 39,919,545 | 40,209,575 | 40,628,924 | 40,519,160 | 40,338,979 | 40,282,688 | 40,219,396 | 39,969,979 | 39,563,888 | 39,113,236 |
Nakit Akışı 12
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $2M | $2M | $719.0K | $800.0K | $2M | $1M | $301.0K | $1M | $1M | $1M | $852.0K | $2M | $173.0K | $3M | $3M | |
| Deferred Tax | $22M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-200.0K | $-3M | $-466.0K | $-2M | $-4M | $-4M | $-2M | $-7M | $2M | $-1M | $-1M | $-694.0K | $-3M | $-6M | $-8M | $-2M | |
| CapEx | $2.0K | $5.0K | $2.0K | $0 | $4.0K | $3.0K | $11.0K | $5.0K | $0 | $2.0K | $3.0K | $32.0K | $20.0K | $199.0K | $308.0K | $121.0K | |
| Investing Cash Flow | $4M | $-19M | $-2M | $38M | $-55M | $24M | $15M | $-34M | $95M | $30M | $30M | $-75M | $-15M | $-13M | $11M | $1M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $-2.0K | $0 | $2M | $4M | $-3M | |
| Stock Repurchased | · | · | $4M | $361.0K | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $78.0K | $10M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-2M | $-10M | $-4M | $-361.0K | · | · | $-1M | $-1M | $-31M | $-19M | $-25M | $75M | $0 | $2M | $4M | $4M | |
| Net Change in Cash | $2M | $-33M | $-6M | $36M | $-59M | $20M | $12M | $-43M | $66M | $10M | $4M | $-1M | $-17M | $-16M | $7M | $3M | |
| Taxes Paid | · | · | · | $-7M | · | · | · | · | · | · | · | $527.0K | $3M | $308.0K | · | $167.0K | |
| Free Cash Flow | · | $-3M | · | · | · | $-4M | · | · | · | $-1M | · | · | · | $-6M | · | · |
Kârlılık 8
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 0.65% | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | · | · | · | · | · | -225.0% | · | · | · | · | · | · | -562.5% | -782.0% | · | -1200.7% | |
| Net Margin | · | · | · | · | · | -382.1% | · | · | · | · | · | · | -177.2% | -542.2% | · | -1063.5% | |
| Pretax Margin | · | · | · | · | · | -352.9% | · | · | · | · | · | · | · | · | · | -1048.8% | |
| EBITDA Margin | · | · | · | · | · | -225.0% | · | · | · | · | · | · | -562.5% | -782.0% | · | -1200.7% | |
| ROA | 29.4% | 18.4% | · | 25.1% | 7.7% | -4.3% | · | -9.9% | 5.4% | 0.85% | · | -1.6% | -0.75% | -2.2% | · | -5.9% | |
| ROE | 33.1% | 20.2% | · | 26.9% | 8.0% | -5.0% | · | -12.8% | 5.6% | 0.97% | · | -2.1% | -0.78% | -2.3% | · | -6.5% | |
| ROIC | -0.67% | -1.2% | · | -0.97% | -1.6% | -3.5% | · | -2.1% | -1.5% | · | · | · | · | · | · | -5.4% |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 6.5 | · | 22.2 | 26.8 | 23.9 | · | 27.1 | 41.1 | 5.3 | · | 2.2 | 141.5 | 31.2 | · | 24.5 | |
| Quick Ratio | 1.5 | 1.7 | · | 9.3 | 4.8 | 0.7 | · | 10.9 | 20.4 | 2.9 | · | 0.0 | 0.9 | 0.5 | · | 0.8 | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | 0.2 | · | 0.5 | 0.0 | 0.0 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -5.0 | · | -3.5 | · | · | · | · |
Verimlilik 1
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | · | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 |
Değerleme (TTM) 15
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Net Income TTM | $178M | $92M | · | $34M | $-5M | $-17M | · | $-12M | $6M | $-6M | · | $-15M | $-22M | $-32M | · | $-36M | |
| Market Cap | $199M | $139M | · | $108M | $92M | $87M | · | $98M | $104M | $118M | · | $105M | $144M | $87M | · | $253M | |
| Enterprise Value | · | · | · | $51M | $74M | · | · | · | · | $54M | · | · | · | · | · | · | |
| P/E | 1.1 | 1.6 | · | 3.4 | -16.1 | -5.2 | · | -8.1 | 17.1 | -19.5 | · | -261.0 | 10.5 | 3.4 | · | 7.0 | |
| P/S | · | · | · | · | · | · | · | 36.4 | 38.7 | 43.9 | · | 39.0 | 53.4 | 32.4 | · | 94.0 | |
| P/B | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 1.0 | 0.6 | · | 1.6 | |
| P / Tangible Book | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 1.0 | 0.6 | · | 1.6 | |
| P / Cash Flow | · | -47.7 | · | · | · | -24.8 | · | · | · | -80.2 | · | · | · | -15.7 | · | · | |
| P / FCF | · | -47.7 | · | · | · | -24.8 | · | · | · | -80.1 | · | · | · | -15.2 | · | · | |
| EV / EBITDA | · | · | · | -20.9 | -29.9 | · | · | · | · | -18.2 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | · | · | · | · | -36.6 | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | 20.0 | · | · | · | · | · | · | |
| Earnings Yield | 87.1% | 63.5% | · | 29.2% | -6.2% | -19.2% | · | -12.3% | 5.8% | -5.1% | · | -0.38% | 9.5% | 29.4% | · | 14.3% | |
| Payout Ratio | · | 27.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $2M | — | $1M | $3M | — |
| Brüt Kâr Marjı % | 0.65% | — | — | — | — |
| Faaliyet Kâr Marjı % | -754.4% | — | -1176.8% | -1502.0% | — |
| Net Gelir | $64M | $-19M | $5M | $-37M | — |
| Seyreltilmiş Hisse Başı Kâr | $1.50 | $-0.48 | $0.14 | $-0.94 | — |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | — | — | 0.3 | — | — |
| Cari Oran | 7.0 | — | 3.1 | 27.3 | — |
| Cari Oran | 2.7 | — | 1.3 | 0.7 | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-9M | — | $-11M | $-28M | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 88 dosya · $64.4M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 30 (+13 önceki Ç'ye göre) | 8 (0 önceki Ç'ye göre) | 19 (-1 önceki Ç'ye göre) | 19 (+5 önceki Ç'ye göre) | -209K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Aquamarine Financial (Cayman) Ltd | $12.083.562 | 2.512.175 | 18,77% | Hisse senetleri |
| Gem Investment Advisors, LLC | $9.614.238 | 1.998.802 | 14,94% | Hisse senetleri |
| MERCER GLOBAL ADVISORS INC /ADV | $9.189.697 | 1.910.540 | 14,28% | Hisse senetleri |
| Murchinson Ltd. | $6.206.314 | 1.290.294 | 9,64% | Hisse senetleri |
| SB Capital Management Inc | $5.415.000 | 1.900.000 | 8,41% | Hisse senetleri |
| BML Capital Management, LLC | $4.166.754 | 866.269 | 6,47% | Hisse senetleri |
| BOOTHBAY FUND MANAGEMENT, LLC | $2.783.249 | 578.638 | 4,32% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $2.162.008 | 449.482 | 3,36% | Hisse senetleri |
| STATE STREET CORP | $1.164.501 | 242.100 | 1,81% | Hisse senetleri |
| Rathbones Group PLC | $1.120.816 | 233.018 | 1,74% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.105.732 | 229.882 | 1,72% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $950.908 | 197.694 | 1,48% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $884.078 | 183.800 | 1,37% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $784.896 | 163.180 | 1,22% | Hisse senetleri |
| STRS OHIO | $643.578 | 133.800 | 1,00% | Hisse senetleri |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $495.247 | 102.962 | 0,77% | Hisse senetleri |
| JANE STREET GROUP, LLC | $470.606 | 97.839 | 0,73% | Hisse senetleri |
| Hillsdale Investment Management Inc. | $429.533 | 89.300 | 0,67% | Hisse senetleri |
| RITHOLTZ WEALTH MANAGEMENT | $405.709 | 84.347 | 0,63% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $402.280 | 83.634 | 0,63% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $287.518 | 59.775 | 0,45% | Hisse senetleri |
| XTX Topco Ltd | $240.130 | 49.923 | 0,37% | Hisse senetleri |
| Nuveen, LLC | $223.203 | 46.404 | 0,35% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $159.682 | 33.198 | 0,25% | Hisse senetleri |
| PRELUDE CAPITAL MANAGEMENT, LLC | $157.350 | 32.713 | 0,24% | Hisse senetleri |
| BAILARD, INC. | $156.219 | 32.478 | 0,24% | Hisse senetleri |
| RHUMBLINE ADVISERS | $147.281 | 30.621 | 0,23% | Hisse senetleri |
| Bank of New York Mellon Corp | $143.016 | 29.733 | 0,22% | Hisse senetleri |
| ALGERT GLOBAL LLC | $139.288 | 28.958 | 0,22% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $137.080 | 28.499 | 0,21% | Hisse senetleri |
| Connor, Clark & Lunn Investment Management Ltd. | $121.246 | 25.207 | 0,19% | Hisse senetleri |
| CITADEL ADVISORS LLC | $120.250 | 25.000 | 0,19% | Alım opsiyonu |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $107.263 | 22.300 | 0,17% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $105.151 | 21.861 | 0,16% | Hisse senetleri |
| PNC Financial Services Group, Inc. | $101.972 | 21.200 | 0,16% | Hisse senetleri |
| Redwood Family Wealth LLC | $99.783 | 20.745 | 0,16% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $91.621 | 19.048 | 0,14% | Hisse senetleri |
| MORGAN STANLEY | $87.994 | 18.294 | 0,14% | Hisse senetleri |
| Sage Capital Management, LLC | $86.474 | 17.977 | 0,13% | Hisse senetleri |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $75.378 | 15.671 | 0,12% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $67.811 | 14.098 | 0,11% | Hisse senetleri |
| CITIGROUP INC | $66.590 | 13.844 | 0,10% | Hisse senetleri |
| JPMORGAN CHASE & CO | $65.461 | 14.108 | 0,10% | Hisse senetleri |
| Invesco Ltd. | $65.272 | 13.570 | 0,10% | Hisse senetleri |
| Y-Intercept (Hong Kong) Ltd | $61.650 | 12.817 | 0,10% | Hisse senetleri |
| Engineers Gate Manager LP | $61.077 | 12.698 | 0,09% | Hisse senetleri |
| Altshuler Shaham Ltd | $53.925 | 11.211 | 0,08% | Hisse senetleri |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $52.096 | 12.895 | 0,08% | Hisse senetleri |
| Glass Jacobson Investment Advisors llc | $50.698 | 10.540 | 0,08% | Hisse senetleri |
| Police & Firemen's Retirement System of New Jersey | $50.115 | 10.419 | 0,08% | Hisse senetleri |
| MARSHALL WACE, LLP | $50.024 | 10.400 | 0,08% | Hisse senetleri |
| Hudson Bay Capital Management LP | $49.375 | 10.265 | 0,08% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $47.706 | 9.918 | 0,07% | Hisse senetleri |
| Steward Partners Investment Advisory, LLC | $42.453 | 8.826 | 0,07% | Hisse senetleri |
| BARCLAYS PLC | $27.917 | 5.804 | 0,04% | Hisse senetleri |
| NEW YORK STATE COMMON RETIREMENT FUND | $25.974 | 5.400 | 0,04% | Hisse senetleri |
| NORTHERN TRUST CORP | $25.503 | 5.302 | 0,04% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $23.218 | 4.827 | 0,04% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $20.283 | 4.217 | 0,03% | Hisse senetleri |
| FEDERATED HERMES, INC. | $19.221 | 3.996 | 0,03% | Hisse senetleri |
| N.E.W. Advisory Services LLC | $16.495 | 3.429 | 0,03% | Hisse senetleri |
| Legal & General Group Plc | $15.979 | 3.322 | 0,02% | Hisse senetleri |
| CITADEL ADVISORS LLC | $15.565 | 3.236 | 0,02% | Hisse senetleri |
| Ameritas Investment Partners, Inc. | $14.853 | 3.088 | 0,02% | Hisse senetleri |
| HUNTINGTON NATIONAL BANK | $14.440 | 3.002 | 0,02% | Hisse senetleri |
| Pioneer Family Office, LLC | $14.430 | 3.000 | 0,02% | Hisse senetleri |
| Russell Investments Group, Ltd. | $13.088 | 2.721 | 0,02% | Hisse senetleri |
| UBS Group AG | $12.987 | 2.700 | 0,02% | Hisse senetleri |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $7.576 | 1.575 | 0,01% | Hisse senetleri |
| MetLife Investment Management, LLC | $7.037 | 1.463 | 0,01% | Hisse senetleri |
| BlackRock, Inc. | $6.768 | 1.407 | 0,01% | Hisse senetleri |
| ROYAL BANK OF CANADA | $6.000 | 1.246 | 0,01% | Hisse senetleri |
| MCF Advisors LLC | $5.162 | 1.073 | 0,01% | Hisse senetleri |
| Caitlin John, LLC | $4.810 | 1.000 | 0,01% | Hisse senetleri |
| McIlrath & Eck, LLC | $3.400 | 1.000 | 0,01% | Hisse senetleri |
| Sterling Capital Management LLC | $3.300 | 686 | 0,01% | Hisse senetleri |
| IFP Advisors, Inc | $2.405 | 500 | 0,00% | Hisse senetleri |
| PROEQUITIES, INC. | $2.310 | 1.000 | 0,00% | Hisse senetleri |
| Golden State Wealth Management, LLC | $1.458 | 303 | 0,00% | Hisse senetleri |
| JONES FINANCIAL COMPANIES LLLP | $999 | 214 | 0,00% | Hisse senetleri |
| HRT FINANCIAL LP | $469 | 97.582 | 0,00% | Hisse senetleri |
| FMR LLC | $332 | 69 | 0,00% | Hisse senetleri |
| SBI Securities Co., Ltd. | $284 | 59 | 0,00% | Hisse senetleri |
| PRICE T ROWE ASSOCIATES INC /MD/ | $135 | 27.909 | 0,00% | Hisse senetleri |
| TrinityBridge Ltd | $56 | 11.675 | 0,00% | Hisse senetleri |
| HARBOUR INVESTMENTS, INC. | $48 | 10 | 0,00% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $29 | 6 | 0,00% | Hisse senetleri |
| ACADIAN ASSET MANAGEMENT LLC | $8 | 1.691 | 0,00% | Hisse senetleri |
Şirket yöneticileri 30 içeriden öğrenenler · 13 yöneticiler · 16 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Nadav Kidron | President and CEO | 30 Mart 2026 F | 3.422.243 | 0 | 0 | $0 |
| Avraham Gabay | Chief Financial Officer | 01 Temmuz 2026 S | 671.785 | 0 | 1 | $-330.854 |
| David Silberman | Chief Financial Officer | 04 Ocak 2024 A | 366.500 | 0 | 0 | $0 |
| Hilla Eisenberg | CFO, Treasurer and Secretary | 26 Şubat 2019 A | — | 0 | 0 | $0 |
| Yifat Hen Zommer | CFO, Treasurer and Secretary | 30 Haziran 2017 A | 46.560 | 0 | 0 | $0 |
| Chaime Orlev | CFO, Treasurer and Secretary | 12 Ekim 2008 A | — | 0 | 0 | $0 |
| Joshua Hexter | COO & CBO | 02 Temmuz 2026 M | 1.073.384 | 0 | 1 | $-611.020 |
| Miriam Kidron | Chief Scientific Officer | 30 Mart 2026 F | 1.133.138 | 0 | 0 | $0 |
| Netanel Derovan | Chief Legal Officer | 26 Mayıs 2023 A | 149.500 | 0 | 0 | $0 |
| Michael Rabinowitz | Chief Commercial Officer | 03 Ocak 2023 S | 126.143 | 0 | 0 | $0 |
| Michael Rabinowitz | Chief Commercial Officer | 03 Ocak 2022 A | 109.468 | 0 | 0 | $0 |
| Mark Daniel Hasleton | VP Business Development | 26 Şubat 2019 A | — | 0 | 0 | $0 |
| Ronald Edward Law | Chief Strategy Officer | 20 Mart 2017 A | — | 0 | 0 | $0 |
| Yehuda Reznick | Yönetim kurulu üyesi | 31 Aralık 2025 A | 105.180 | 0 | 0 | $0 |
| Daniel Aghion | Yönetim kurulu üyesi | 31 Aralık 2025 A | 113.441 | 0 | 0 | $0 |
| Benjamin Shapiro | Yönetim kurulu üyesi | 31 Aralık 2025 A | 123.220 | 0 | 0 | $0 |
| Arie Mayer | Yönetim kurulu üyesi | 31 Aralık 2025 A | 168.009 | 0 | 0 | $0 |
| Leonard Sank | Yönetim kurulu üyesi | 05 Haziran 2025 A | 134.531 | 0 | 0 | $0 |
| Yadin Rozov | Yönetim kurulu üyesi | 04 Ocak 2024 A | 155.320 | 0 | 0 | $0 |
| Kevin Rakin | Yönetim kurulu üyesi | 21 Mart 2022 S | 46.661 | 0 | 0 | $0 |
| Aviad Friedman | Yönetim kurulu üyesi | 03 Ocak 2022 G | 0 | 0 | 0 | $0 |
| Gao Xiaoming | Yönetim kurulu üyesi | 08 Ocak 2020 A | — | 0 | 0 | $0 |
| David Mark Slager | Yönetim kurulu üyesi | 15 Nisan 2019 A | 1.316.328 | 0 | 0 | $0 |
| Xiaopeng Li | Yönetim kurulu üyesi | 02 Ağustos 2017 P | 206.350 | 0 | 0 | $0 |
| Harold Jacob | Yönetim kurulu üyesi | 10 Mart 2016 S | 16.396 | 0 | 0 | $0 |
| Michael Berelowitz | Yönetim kurulu üyesi | 09 Aralık 2015 S | 22.896 | 0 | 0 | $0 |
| Gerald M Ostrov | Yönetim kurulu üyesi | 23 Şubat 2015 A | 24.896 | 0 | 0 | $0 |
| REGALS CAPITAL MANAGEMENT LP | 10% sahip | 23 Aralık 2015 X | 1.186.823 | 0 | 0 | $0 |
| Zeev Bronfeld | 10% sahip | 27 Eylül 2011 S | 5.808.517 | 0 | 0 | $0 |
| Michael Young | — | 27 Mayıs 2004 S | 0 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 9 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. | 22 Temmuz 2026 | 3,30% | Değişiklik | — | SEC |
| Nadav Kidron ×8 başvurular | 28 Ağustos 2025 | 7,60% | Değişiklik | — | SEC |
| Regals Capital Management LP, Regals Fund LP, David M. Slager ×2 başvurular | 20 Temmuz 2018 | — | İlk başvuru | — | SEC |
| Hefei Tianhui Incubator of Technologies Co., Ltd | 06 Ocak 2016 | — | İlk başvuru | — | SEC |
| Leonard Sank | 15 Aralık 2014 | — | İlk başvuru | Pasif yatırım | SEC |
| Miriam Kidron ×2 başvurular | 03 Şubat 2014 | — | İlk başvuru | — | SEC |
| Zeev Bronfeld | 06 Mart 2006 | — | İlk başvuru | Pasif yatırım | SEC |
| Açıklanmayan raporlama kişisi | 10 Haziran 2004 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 10 Haziran 2004 | — | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 14 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IWC · iShares Trust | 0,03% | 114.970 SH | 08 Ağustos 2026 | Günlük |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 7.046 SH | 08 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 29.637 SH | 08 Ağustos 2026 | Günlük |
| IWN · iShares Trust | 0,01% | 315.439 SH | 08 Ağustos 2026 | Günlük |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 28.155 NS | 31 Mayıs 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 621.705 SH | 08 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,00% | 26.896 NS | 30 Nisan 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4.523 NS | 30 Nisan 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 36.536 NS | 30 Nisan 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 4.152 NS | 31 Mayıs 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 3.431 NS | 30 Nisan 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 196.765 SH | 08 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.480 SH | 08 Ağustos 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,00% | 4 NS | 30 Nisan 2026 | N-PORT |